Literature DB >> 27628318

Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer.

Agnes Assao1, Suely Nonogaki2, José Roberto Pereira Lauris3, André Lopes Carvalho4, Clóvis Antônio Lopes Pinto5, Fernando Augusto Soares5, Luiz Paulo Kowalski6, Denise Tostes Oliveira7.   

Abstract

INTRODUCTION: Podoplanin and ezrin connection through Rho-A phosphorylation have been suggested as part of the activation pathway, in the process of tumor invasion and cell movement in oral squamous cell carcinomas.
OBJECTIVE: The aim of this study was to evaluate the correlation among podoplanin, ezrin, and Rho-A immunoexpressions in 91 squamous cells carcinomas of the lower lip and their influence in patient's prognosis.
MATERIAL AND METHODS: The immunoexpressions of podoplanin, ezrin, and Rho-A were evaluated through a semi-quantitative score method, based on the capture of 10 microscopic fields at the front of tumor invasion. The association and correlation of these proteins with the clinicopathological features were verified by Fischer's exact test and Spearman's test. The prognostic values were analyzed by Kaplan-Meier method and log-rank test.
RESULTS: A statistically significant association between strong cytoplasmic podoplanin expression and alcohol (p = 0.024), loco-regional recurrences (p = 0.028), and lymph node metastasis (pN+) (p = 0.010) was found. The membranous (p = 0.000 and r = 0.384) and cytoplasmic (p = 0.000 and r = 0.344) podoplanin expression was statistically correlated with ezrin expression. Also, membranous podoplanin was significantly correlated with Rho-A expression (p = 0.006 and r = 0.282). The expressions of podoplanin, ezrin, and Rho-A were not significant prognostic factors for patients with squamous cell carcinomas of the lower lip.
CONCLUSIONS: Therefore, our results confirm a correlation among podoplanin, ezrin, and Rho-A expressions in squamous cell carcinoma of the lip suggesting a cooperative participation of these proteins in cell movement and invasion. CLINICAL RELEVANCE: Furthermore, strong cytoplasmic podoplanin expression could be helpful to identify patients with squamous cell carcinoma of the lip and lower risk of loco-regional recurrences.

Entities:  

Keywords:  Ezrin; Oral cancer; Podoplanin; Rho-A

Mesh:

Substances:

Year:  2016        PMID: 27628318     DOI: 10.1007/s00784-016-1956-3

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  37 in total

1.  Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance.

Authors:  Aroldo dos Santos Almeida; Denise Tostes Oliveira; Michele Conceição Pereira; Simone Eloiza Sita Faustino; Suely Nonogaki; André Lopes Carvalho; Luiz Paulo Kowalski
Journal:  Anticancer Res       Date:  2013-09       Impact factor: 2.480

2.  Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.

Authors:  Akinori Funayama; Jun Cheng; Satoshi Maruyama; Manabu Yamazaki; Takanori Kobayashi; Mei Syafriadi; Sukalyan Kundu; Susumu Shingaki; Chikara Saito; Takashi Saku
Journal:  Pathobiology       Date:  2011-05-26       Impact factor: 4.342

3.  Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin.

Authors:  Leah N Cueni; Ivan Hegyi; Jay W Shin; Andrea Albinger-Hegyi; Silke Gruber; Rainer Kunstfeld; Holger Moch; Michael Detmar
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

4.  Motility-related proteins as markers for head and neck squamous cell cancer.

Authors:  M T Abraham; M A Kuriakose; P G Sacks; H Yee; L Chiriboga; E L Bearer; M D Delacure
Journal:  Laryngoscope       Date:  2001-07       Impact factor: 3.325

5.  Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity.

Authors:  Harumi Inoue; Yuji Miyazaki; Kentaro Kikuchi; Noriaki Yoshida; Fumio Ide; Yoshihiro Ohmori; Akihito Tomomura; Hideaki Sakashita; Kaoru Kusama
Journal:  Tumour Biol       Date:  2011-11-12

6.  Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.

Authors:  Gerhard Frank Huber; Florian R Fritzsche; Lena Züllig; Martina Storz; Nicole Graf; Stephan K Haerle; Wolfram Jochum; Sandro J Stoeckli; Holger Moch
Journal:  Int J Cancer       Date:  2011-02-11       Impact factor: 7.396

7.  Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures.

Authors:  Masayuki Tsuneki; Satoshi Maruyama; Manabu Yamazaki; Jun Cheng; Takashi Saku
Journal:  Pathol Res Pract       Date:  2012-02-10       Impact factor: 3.250

8.  Surgical management of squamous cell carcinoma of the lip: analysis of a 10-year experience in 223 patients.

Authors:  Miroslav Vukadinovic; Zoran Jezdic; Milan Petrovic; Ljiljana M Medenica; Marko Lens
Journal:  J Oral Maxillofac Surg       Date:  2007-04       Impact factor: 1.895

9.  Mechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinoma.

Authors:  Shota Saito; Hiroto Yamamoto; Ken-ichi Mukaisho; Sho Sato; Tomoki Higo; Takanori Hattori; Gaku Yamamoto; Hiroyuki Sugihara
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability.

Authors:  E Martín-Villar; B Borda-d'Agua; P Carrasco-Ramirez; J Renart; M Parsons; M Quintanilla; G E Jones
Journal:  Oncogene       Date:  2014-12-08       Impact factor: 9.867

View more
  3 in total

1.  Prognostic Implications of ALDH1 and Notch1 in Different Subtypes of Oral Cancer.

Authors:  Silas Antonio Juvencio de Freitas Filho; Cláudia Malheiros Coutinho-Camillo; Katia Klug Oliveira; Bárbara Beltrame Bettim; Clóvis Antônio Lopes Pinto; Luiz Paulo Kowalski; Denise Tostes Oliveira
Journal:  J Oncol       Date:  2021-02-13       Impact factor: 4.375

Review 2.  Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.

Authors:  Byeong-Oh Hwang; Se-Young Park; Eunae Sandra Cho; Xianglan Zhang; Sun Kyoung Lee; Hyung-Joon Ahn; Kyung-Soo Chun; Won-Yoon Chung; Na-Young Song
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

3.  Podoplanin Drives Motility of Active Macrophage via Regulating Filamin C During Helicobacter pylori Infection.

Authors:  Yi Ying Cheok; Grace Min Yi Tan; Keith Conrad Fernandez; Yee Teng Chan; Chalystha Yie Qin Lee; Heng Choon Cheong; Chung Yeng Looi; Jamuna Vadivelu; Suhailah Abdullah; Won Fen Wong
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.